Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Perrigo Haunted By Mylan Rejection As Securities Fraud Complaints Mount

Oct 31 2018

• By Eileen Francis

Related Content

Another Change At Perrigo Helm As Results Remain Turbulent

Oct 09 2018

Shareholders Challenge Perrigo's Defense Against Mylan Offer Two Years Earlier

Nov 07 2017

Perrigo Shareholder Lawsuits Claim Joining Mylan Was A Better Idea

Jul 25 2016

Perrigo Stands Alone At Top OF OTC Private Label Market, In Hunt For More Deals

Nov 16 2015

Perrigo's OTC Core Could Expand To Include National Brands

Aug 10 2018

Perrigo Looks To Spin Out Or Sell Off Rx Business, But Will Separating Generics Add Value?

Aug 10 2018

Related Companies

Perrigo Company PLC

Viatris Inc.

Omega Pharma NV

Additional Topics

United States Legal Issues M & A Advertising, Marketing & Sales Business Strategies Companies Deals OTC Drugs Consumer

More from Legal & IP

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window